Benzofuran structures and their derivatives are found in many compounds that are of current interest due to their broad range of biological activity. A wide variety of existing drugs,which contain benzofurans have been developed. Amiodarone [1] is an antiarrhythmic drug developed in the early 1960s. Galanthamine [2] is marketed under the name Reminyl for the treatment of Alzheimer’s disease. Ramelteon [3] is developed by the Takeda Corporation and approved in the US for the treatment of insomnia. Prucalopride [4] is a new drug developed by Janssen for the treatment of irritable bowl syndrome and constipation.
Based on the wide range activity of benzofuran and its derivatives,the synthesis of such compounds has been a focus in organic chemistry research. 3-Hydroxymethylbenzofuran,an important intermediate of active benzofuran derivatives [5, 6, 7, 8],is usually synthesized by the reduction of benzofuran-3-carbaldehyde with NaBH4 [9, 10]. In this paper,we report a new method for the synthesis of 3-hydroxymethylbenzofuran.
2. ExperimentalAll reagents were obtained commercially and used without further purification. The solvents used were all of AR grade and were dried over standard drying agents or freshly distilled where necessary. 1H NMR and 13C NMR spectra were recorded in CDCl3 on a Varan Mercury300 spectrometer using TMS as an internal standard. Coupling constant (J) values were given in Hz. Mass spectra were determined with Agilent 6520 Accurate-Mass Q-TOF LC/MS.
General procedure for 3-hydroxymethylbenzofuran derivatives: To a solution of 2 (1 mmol) in THF (2 mL),HCl (1 mol/L,2 mL) was added. The mixture was heated to 60 ℃ and stirred for 2-12 h and then cooled to room temperature. The reaction was quenched with saturated NaHCO3 aqueous,extracted with EtOAc (3×5 mL) and washed with water. The organic layer was dried (Na2SO4),filtered, and evaporated under reduced pressure. The resulting crude product was purified by silica gel column chromatography (PE:EtOAc = 5:1) to afford 3 [11] (Table 1).
![]() |
Table 1 Synthesis of 3-hydroxymethylbenzofuran derivatives. |
During the study on selectively cleavage of the MOM group on alcoholic hydroxyl of compound 1,an interesting result was observed. Treatment of compound 1 with 1 mol/L HCl in MeOH led to compound 2 as the major product. However,the reaction was carried out in THF,compound 3 was detected as the major product (Scheme 1).
![]() |
Download:
|
Scheme 1 Different deprotection products in different solvent. |
The probable mechanism of this formation was shown in Scheme 2. In an acidic condition,the MOM groups on alcoholic hydroxyl and phenolic hydroxyl were both removed to produce intermediate 4,which was cyclized to produce α-hydroxyhemiacetal intermediate 5 by intramolecular addition. A similar mechanism for this formation had been reported by Nishino [12]. The intermediate 5 was dehydrated to produce intermediate 6,which was then converted to compound 3 by addition and electron transfer. This is a new pathway to construct 3-hydroxymethylbenzofuran derivatives.
![]() |
Download:
|
Scheme 2 Probably mechanism for 3-hydroxymethylbenzofuran derivatives formation. |
To investigate this proposed mechanism,the designed reaction was carried out. Deprotection of compound 7 afforded tautomeric intermediate 4 and 5 (1:1),as revealed by 1H NMR spectroscopy [13]. The tautomeric mixture was treated with TBSCl in alkaline condition to obtain compound 8. The tautomeric mixture was treated in acidic condition to obtain compound 3 (Scheme 3). This supported that intermediate 4 is not stable in the solution,as the hypothesized mechanism predicts. The reaction equilibrium was moved to intermediate 5 to give 3 after addition and electron transfer.
![]() |
Download:
|
Scheme 3 Certification of the probably mechanism. |
To study the applicability of this new method,other substances were discussed as follows (Table 1): when the aromatic nucleus was benzene,the yield of this product was excellent,but when the aromatic nucleus was naphthalene,the product was barely detected by LC-MS. This yield could not be improved,not even by lowering the reaction temperature or reducing the concentration of hydrochloric acid. We proposed that the naphthalene-type intermediate was unstable,resulting in the decomposition of the substances.
4. ConclusionIn conclusion,we developed a new method to furnish 3- hydroxymethylbenzofuran derivatives. This reaction was carried out under acidic condition in THF at reflux. The key step of the reaction mechanism for this process was a chemical equilibrium shift of tautomer. Further studies and the extensions of this method in the preparation of other 3-hydroxymethylbenzofuran derivatives are currently underway.
AcknowledgmentsThe project was supported by the National Mega-Project for Innovative Drugs (No. 2012zx09301002-002) and State Key Laboratory of Bioactive Substance and Function of Natural Medicines.
[1] | J.C. Somberg, (N-alkyl-N-hydroxymethylamino)alkoxybenzoylbenzofurans and the phosphate esters thereof, US Patent 5981514, 1999. |
[2] | G. Orhan, I. Orhanand, B. Sener, Recent developments in natural and synthetic drug research for Alzheimer's disease, Lett. Drug Des. Discov. 3 (2006) 268-274. |
[3] | A. McGechan, K. Wellington, Ramelteon, CNS Drugs 19 (2005) 1057-1065. |
[4] | J. Schuurkes, J. Adrianus, Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia, Aust Patent 770580B, 2004. |
[5] | R. Hersperger, P. Janser, E. Pfenninger, et al., Preparation of 1H-indole-2-carboxylic acid N-(piperidin-4-yl)amides and related derivatives as chemokine receptor, particularly CCR2 and CCR5 antagonists, WO Patent 2005077932, 2005. |
[6] | W. Eccles, J.M. Blevitt, J.N. Booker, et al., Identification of benzofuran central cores for the inhibition of leukotriene A4 hydrolase, Bioorg. Med. Chem. Lett. 23 (2013) 811-815. |
[7] | A. Fuerstner, P.W. Davies, Heterocycles by PtCl2-catalyzed intramolecular carboalkoxylation or carboamination of alkynes, J. Am. Chem. Soc. 127 (2005) 15024-15025. |
[8] | D.C. Horwell, W. Howson, M. Higginbottom, et al., Quantitative structure-activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity matrixes, J. Med. Chem. 38 (1995) 4454-4462. |
[9] | A. Shafiee, M. Mohamadpour, Synthesis of 3-formylbenzo[b]furan and 1-methyl- 3,4-dihydrobenzo[b]-furo [2,3-c], J. Heterocycl. Chem. 15 (1978) 481-483. |
[10] | P.V. Podea, M.I. Toşa, C. Paizs, et al., Chemoenzymatic preparation of enantiopure L-benzofuranyl- and L-benzo[b]thiophenyl alanines, Tetrahedron: Asymmetry 19 (2008) 500-511. |
[11] | Analytical data for compound: 3a: 1H NMR (300 MHz, CDCl3): δ 7.58 (m, 1H), 7.39 (m, 1H), 7.23 (m, 2H), 4.74 (s, 2H), 2.45 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 154.2, 153.0, 128.6, 123.8, 122.8, 119.2, 114.4, 110.9, 55.7, 12.3; HR-ESI-MS: calcd. for C10H10NaO2+: 185.0573; found: 185.0579 [M+Na]+. 3b: 1H NMR (300 MHz, CDCl3): δ 7.40 (d, 1H, J = 7.8 Hz), 6.16 (s, 1H), 7.00 (d, 1H, J = 7.8 Hz), 4.64 (s, 2H), 2.42 (s, 3H), 2.37 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 154.5, 152.2, 133.8, 126.1, 124.0, 118.6, 114.2, 111.1, 55.5, 21.7, 12.1; HR-ESI-MS: calcd. for C11H12NaO2+: 199.0730; found 199.0735 [M+Na]+. 3c: 1H NMR (300 MHz, CDCl3): δ 7.51 (d, 1H, J = 7.8 Hz), 7.42 (s, 1H), 7.293 (d, 1H, J = 7.8 Hz), 4.73 (s, 2H), 2.43 (s, 3H), 1.36 s (s, 9H); 13C NMR (75 MHz, CDCl3): δ 154.6, 152.6, 147.8, 125.9, 120.5, 118.5, 114.2, 107.7, 55.8, 35.1, 31.9, 12.3; HR-ESI-MS: calcd. for C14H18NaO2+: 241.1199; found 241.1203 [M+Na]+. |
[12] | Z.Q. Cong, H. Nishino, Synthesis of unusual naphtho[2,1-b]furans and novel 1Hbenz[e]indolinones via selective intramolecular cyclization, Heterocycles 78 (2009) 397-413. |
[13] | 1HNMRdata for compound: 4: 1HNMR(300 MHz, CDCl3): δ 7.82 (brs, 1H), 7.16 (s, 1H), 6.75 (s, 1H), 6.61 (s, 1H), 2.30 (s, 3H), 2.05 (s, 3H), 1.72 (s, 3H). 5: 1H NMR (300 MHz, CDCl3): δ 7.19 (s, 1H), 6.75 (s, 1H), 6.69 (s, 1H), 2.30 (s, 3H), 1.54 (s, 3H), 1.51 (s, 3H). |